- Disease: Acute SARS-CoV-2
- Study type: Observational Cohort Study
- Study type descriptors: Retrospective, Single centre
- Study aim: To describe the real-world effectiveness of a 5-day course of remdesivir for the treatment of severe pneumonia according to SARS-CoV-2 vaccination status
- Number of participants enrolled: 708
- Study enrolling from to
- Study includes follow-up for 1 month
Study Data
- Adults
- Elderly
- Fragile population
- Paediatric
- Hospital wide
- SARS-CoV-2
- Acute SARS-CoV-2
- Pharmacological intervention
- Antivirals
- Remdesivir
External Links
Other information
If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it
The data is updated up to